Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Jose Antonio Lopez- Guerrero"'
Autor:
Sukanya Chakraborty, Aaqib M. Bhat, Insha Mushtaq, Haitao Luan, Achyuth Kalluchi, Sameer Mirza, Matthew D. Storck, Nagendra Chaturvedi, Jose Antonio Lopez-Guerrero, Antonio Llombart-Bosch, Isidro Machado, Katia Scotlandi, Jane L. Meza, Gargi Ghosal, Donald W. Coulter, M. Jordan Rowley, Vimla Band, Bhopal C. Mohapatra, Hamid Band
Publikováno v:
Communications Biology, Vol 6, Iss 1, Pp 1-21 (2023)
Abstract Overexpression of the EPS15 Homology Domain containing 1 (EHD1) protein has been linked to tumorigenesis but whether its core function as a regulator of intracellular traffic of cell surface receptors plays a role in oncogenesis remains unkn
Externí odkaz:
https://doaj.org/article/09e76c7a25c7457f98d7a6fdc6e884ba
Autor:
Andres Poveda, Ana Oaknin, Ignacio Romero, Angel Guerrero-Zotano, Lorena Fariñas-Madrid, Victor Rodriguez-Freixinos, Pedro Mallol, Raquel Lopez-Reig, Jose Antonio Lopez-Guerrero
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-11 (2021)
Abstract The poly (ADP-Ribose) polymerase (PARP) inhibitor olaparib has shown antitumor activity in patients with ovarian or breast cancer with or without BRCA1/2 mutations. Lurbinectedin is an ecteinascidin that generates DNA double-strand breaks. W
Externí odkaz:
https://doaj.org/article/d1515ed3222c482292aa0ffa3a73aad2
Autor:
Zaida Garcia-Casado, Ana Oaknin, Marta Mendiola, Gorka Alkorta-Aranburu, Jose Ramon Antunez-Lopez, Gema Moreno-Bueno, Jose Palacios, Alfonso Yubero, Raul Marquez, Alejandro Gallego, Ana Beatriz Sanchez-Heras, Jose Antonio Lopez-Guerrero, Cristina Perez-Segura, Pilar Barretina-Ginesta, Jesus Alarcon, Lydia Gaba, Antonia Marquez, Judit Matito, Juan Cueva, Isabel Palacio, Maria Iglesias, Angels Arcusa, Luisa Sanchez-Lorenzo, Eva Guerra-Alia, Ignacio Romero, Ana Vivancos
Publikováno v:
Scientia
Journal of Personalized Medicine; Volume 12; Issue 11; Pages: 1842
Journal of Personalized Medicine; Volume 12; Issue 11; Pages: 1842
Germline and tumor BRCA testing constitutes a valuable tool for clinical decision-making in the management of epithelial ovarian cancer (EOC) patients. Tissue testing is able to identify both germline (g) and somatic (s) BRCA variants, but tissue pre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bac3e9951412027604b384b35ccd4809
https://hdl.handle.net/11351/8598
https://hdl.handle.net/11351/8598
Autor:
Zaida, Garcia-Casado, Ana, Oaknin, Marta, Mendiola, Gorka, Alkorta-Aranburu, Jose Ramon, Antunez-Lopez, Gema, Moreno-Bueno, Jose, Palacios, Alfonso, Yubero, Raul, Marquez, Alejandro, Gallego, Ana Beatriz, Sanchez-Heras, Jose Antonio, Lopez-Guerrero, Cristina, Perez-Segura, Pilar, Barretina-Ginesta, Jesus, Alarcon, Lydia, Gaba, Antonia, Marquez, Judit, Matito, Juan, Cueva, Isabel, Palacio, Maria, Iglesias, Angels, Arcusa, Luisa, Sanchez-Lorenzo, Eva, Guerra-Alia, Ignacio, Romero, Ana, Vivancos
Publikováno v:
Journal of personalized medicine. 12(11)
Germline and tumor
Autor:
Andrew S Brohl, David A Solomon, Wendy Chang, Jianjun Wang, Young Song, Sivasish Sindiri, Rajesh Patidar, Laura Hurd, Li Chen, Jack F Shern, Hongling Liao, Xinyu Wen, Julia Gerard, Jung-Sik Kim, Jose Antonio Lopez Guerrero, Isidro Machado, Daniel H Wai, Piero Picci, Timothy Triche, Andrew E Horvai, Markku Miettinen, Jun S Wei, Daniel Catchpool, Antonio Llombart-Bosch, Todd Waldman, Javed Khan
Publikováno v:
PLoS Genetics, Vol 10, Iss 7, p e1004475 (2014)
The Ewing sarcoma family of tumors (EFT) is a group of highly malignant small round blue cell tumors occurring in children and young adults. We report here the largest genomic survey to date of 101 EFT (65 tumors and 36 cell lines). Using a combinati
Externí odkaz:
https://doaj.org/article/7422003c4829425facb07fc765958f49
Autor:
Alejandro Gallego, Cristina Perez Segura, Juan Cueva, Zaida García-Casado, Ignacio A. Romero, Alfonso Yubero Esteban, Isabel Palacio Vázquez, Judit Matito, Ana Beatriz Sanchez, Lorena Fariñas-Madrid, Ana Vivancos, Jesus Alarcon, Ana Oaknin, Andres Poveda, Jose Antonio Lopez Guerrero, Raul Marquez, Maria Pilar Barretina-Ginesta
Publikováno v:
JOURNAL OF CLINICAL ONCOLOGY
r-FISABIO. Repositorio Institucional de Producción Científica
instname
Publons
r-FISABIO: Repositorio Institucional de Producción Científica
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
r-FISABIO. Repositorio Institucional de Producción Científica
instname
Publons
r-FISABIO: Repositorio Institucional de Producción Científica
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
6055 Background: Epithelial ovarian cancer (EOC) identification of BRCA1 and BRCA2 mutations is usually carried out in germline, representing around 17% in high grade serous ovarian cancer (HGSOC) and further 5-7% are only identified in the tumor (so
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bcee1ff10eb4c2a378851890f04ca90e
https://fundanet.fisabio.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=9128
https://fundanet.fisabio.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=9128
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Jesus Garcia-Donas, Alicia Hurtado, Laia Garrigos, Ana Santaballa, Andres Redondo, Laura Vidal, Nuria Lainez, Eva Guerra, Victor Rodriguez, Juan Cueva, Isabel Bover, Isabel Palacio, Maria Jesus Rubio, Mario Prieto, Jose Antonio Lopez-Guerrero, Juan Francisco Rodriguez-Moreno, Zaida Garcia-Casado, Elena Garcia-Martinez, Alvaro Taus, Ignacio Pérez de Castro, Paloma Navarro, Susana Hernando, Enrique Grande
Publikováno v:
SSRN Electronic Journal.
Autor:
Carlos Loucera, Gloria Peiro, Marta Ramírez-Calvo, Joaquín Dopazo, Jose Antonio Lopez Guerrero, Antonio Fernandez-Serra, Begoña Bermejo, Sonia Servitja, Antonio Llombart-Cussac, Maria Jesus Peña, Ignacio Tusquets, Angel Guerrero-Zotano, Octavio Burgues, J Palacios, Joan Albanell
Publikováno v:
Journal of Clinical Oncology. 39:558-558
558 Background: Genomic platforms, such as Mammaprint (Agendia) (MP) and OncoType (Genomic Health) (OT), have been validated to determine the risk of relapse in therapeutic decision-making in early-stage hormone receptor positive (HR+), epidermal gro
Autor:
Ignacio Romero, Ana Oaknin, Zaida Garcia-Casado, Raul Marquez, Alfonso Yubero Esteban, Alejandro Gallego, Ana Beatriz Sanchez, Cristina Pérez Segura, Jesus Alarcon Company, Pilar Barretina Ginesta, Isabel Palacio Vázquez, Lorena Fariñas Madrid, Juan Fernando Cueva, Judit Matito, Andres Poveda, Jose Antonio Lopez-Guerrero, Ana Vivancos
Publikováno v:
Journal of Clinical Oncology. 39:e17550-e17550
e17550 Background: In epithelial ovarian cancer (EOC), the identification of mutations in homologous recombination repair (HRR) genes on tumor is prognostic, predictive of response to PARP inhibitors, and a tool to identify individuals at genetic can